Related Experiment Video
Updated: Sep 2, 2025
06:55
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
14.6K
Intent-to-Treat (ITT) vs Completer or Per-Protocol Analysis in Randomized Controlled Trials
1Dept. of Clinical Psychopharmacology and Neurotoxicology, National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India.
Indian Journal of Psychological Medicine
|August 11, 2022
Summary
Randomized controlled trials (RCTs) face bias from post-dropout events. Intent-to-treat (ITT) analysis includes all patients, reflecting real-world use, while completer analysis focuses on ideal adherence.
Area of Science:
- Clinical Trials
- Biostatistics
- Epidemiology
Background:
- Randomization in clinical trials balances baseline characteristics.
- Post-randomization events, such as patient dropouts, can introduce bias.
- Maintaining balance after randomization is crucial for trial validity.
Purpose of the Study:
- To discuss data analysis methods for randomized controlled trials with dropouts.
- To compare completer analysis and intent-to-treat (ITT) analysis.
- To highlight the impact of postrandomization biases on study outcomes.
Main Methods:
- Comparison of completer analysis (including per-protocol analysis) and intent-to-treat (ITT) analysis (including modified ITT [mITT]).
- Discussion of the advantages and disadvantages of each analysis method.
- Brief overview of handling missing data in ITT and mITT.
Main Results:
- Completer analyses reflect ideal adherence scenarios.
- ITT analyses represent real-world patient adherence and outcomes.
- Postbaseline events, like dropouts, disrupt initial randomization balance.
Conclusions:
- The choice of analysis method (completer vs. ITT) impacts the interpretation of trial results.
- ITT analysis provides a more pragmatic view of treatment effectiveness in routine practice.
- Understanding and addressing postrandomization biases is essential for accurate clinical trial interpretation.
Keywords:
Intent-to-treat (ITT) analysiscompleter analysisdata imputationper-protocol analysispostrandomization biasrandomized controlled trialsMore Related Videos
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
10.8K
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
687
Related Concept Videos
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
164
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
164
01:16Clinical Trials
7.0K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
7.0K
01:11Blinding
2.5K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.5K
01:20Comparing the Survival Analysis of Two or More Groups
266
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
266
01:11Clinical Trials: Overview
3.3K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.3K
01:12Analysis of Population Pharmacokinetic Data
371
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
371